Elisa Agostinetto: The Results of the NEOENDO Translational Study by Francesco Schettini, et al.
Elisa Agostinetto, Medical Research Fellow at the University Hospital of Brussels, shared an article by F. Schettini on X:
“Now out in ESMO Open results of the NEOENDO translational study by Francesco Schettini & Aleix Prat team identifying predictors of response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in HR+/HER2– BC.”
Identifying predictors of treatment response and molecular changes induced by neoadjuvant chemotherapy and endocrine therapy in hormone receptor-positive/HER2-negative breast cancer: the NEOENDO translational study.
Authors: F. Schettini, et al.
Dr. Elisa Agostinetto is a medical oncologist, specializing in breast cancer research. Elisa Agostinetto is a Medical Research Fellow at the University Hospital of Brussels since November 2021. Additionally, she has serves as a Clinical Research Fellow at Jules Bordet Institute. Her work focuses on clinical research in oncology, likely involving various aspects of cancer treatment and patient care. Actively engaged in professional societies like ESMO, ASCO, and BSMO, she also contributes as a young investigator in the EORTC Breast Cancer Working Group and as a Committee member of the Young Cancer Professionals within the European Cancer Organization.
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023